Literature DB >> 24806955

Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease.

F Fanelli1, A Cannavale, M Gazzetti, P Lucatelli, A Wlderk, C Cirelli, A d'Adamo, F M Salvatori.   

Abstract

PURPOSE: This study was designed to assess the effect of calcium on the efficacy of DEB during revascularization of steno-obstructive SFA lesions.
METHODS: Sixty patients with de novo lesions of the superficial femoral artery underwent endovascular treatment with drug eluting balloons (DEB). DEB was selected according to vessel reference diameter (1:1). In case of residual stenosis > 50 % or flow-limiting dissection, postdilatation with conventional balloon or provisional stenting was done. Patients were classified into eight groups according to circumferential distribution of calcium on CT-angiography axial images (from 0° to 360°) and to its length (length < or > 3 cm) evaluated with digital-subtraction-angiography. Ankle-brachial index (ABI), late lumen loss (LLL), target lesion revascularization (TLR), primary (PP) and secondary (SP) patency, major adverse events (MAE), and Rutherford shift were evaluated at 1-year follow-up and correlated with the amount of calcium.
RESULTS: Revascularization was successful in all cases. Flow-limiting dissection occurred in five cases (8.3 %) with a higher circumferential degree of calcium and solved in three cases with postdilatation and in the other two with provisional stenting. DEB effect was lower in patients with higher degree of calcium (>270° vs. <90°): ABI 0.71 ± 0.07 versus 0.92 ± 0.07; LLL 0.75 ± 0.21 versus 0.45 ± 0.1; PP 50 versus 100 %; SP 50 versus 100 %; TLR 25 versus 0 %; MAE 25 versus 0 %.
CONCLUSIONS: Calcium represents a barrier to optimal drug absorption. Circumferential distribution seems to be the most influencing factor with the worst effect noticed in 360° calcium presence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24806955     DOI: 10.1007/s00270-014-0904-3

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  39 in total

1.  Association of cardiovascular and biochemical risk factors with tibial artery calcification.

Authors:  Dale S Deas; Andre P Marshall; Aihua Bian; Ayumi Shintani; Raul J Guzman
Journal:  Vasc Med       Date:  2015-04-23       Impact factor: 3.239

2.  Drug-coated balloons: how should we incorporate into our practice in treating superficial femoral artery lesions?

Authors:  Thomas Zeller; Aljoscha Rastan; Roland Macharzina; Ulrich Beschorner; Elias Noory
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-05

Review 3.  Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.

Authors:  David Marlevi; Elazer R Edelman
Journal:  J Am Coll Cardiol       Date:  2021-05-18       Impact factor: 24.094

4.  Comparison of ante-versus retrograde access for the endovascular treatment of long and calcified, de novo femoropopliteal occlusive lesions.

Authors:  Sorin Giusca; Micheal Lichtenberg; Saskia Hagstotz; Christoph Eisenbach; Hugo A Katus; Christian Erbel; Grigorios Korosoglou
Journal:  Heart Vessels       Date:  2019-09-17       Impact factor: 2.037

5.  Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.

Authors:  Abhisekh Mohapatra; Zein Saadeddin; Daniel J Bertges; Michael C Madigan; Georges E Al-Khoury; Michel S Makaroun; Mohammad H Eslami
Journal:  J Vasc Surg       Date:  2019-08-10       Impact factor: 4.268

6.  Percutaneous intentional intra-luminal-assisted recanalization (PILAR technique) of challenging chronic total occlusions using a high-frequency vibration device.

Authors:  Stephanie Volpi; Amine Chouiter; Francois Saucy; Steven Hajdu; Anne-Marie Jouannic; Salah D Qanadli
Journal:  Eur Radiol       Date:  2018-05-22       Impact factor: 5.315

7.  Calcified plaque modification alters local drug delivery in the treatment of peripheral atherosclerosis.

Authors:  Abraham R Tzafriri; Fernando Garcia-Polite; Brett Zani; James Stanley; Benny Muraj; Jennifer Knutson; Robert Kohler; Peter Markham; Alexander Nikanorov; Elazer R Edelman
Journal:  J Control Release       Date:  2017-09-01       Impact factor: 9.776

8.  Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients.

Authors:  Abraham R Tzafriri; Benny Muraj; Fernando Garcia-Polite; Antonio G Salazar-Martín; Peter Markham; Brett Zani; Anna Spognardi; Mazen Albaghdadi; Steve Alston; Elazer R Edelman
Journal:  Biomaterials       Date:  2020-08-20       Impact factor: 12.479

9.  Treatment of femoro-popliteal lesions with scoring and drug-coated balloon angioplasty: 12-month results of the DCB-Trak registry.

Authors:  Magnus Baumhäkel; Shalva Chkhetia; Michael Kindermann
Journal:  Diagn Interv Radiol       Date:  2018 May-Jun       Impact factor: 2.630

Review 10.  [Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence].

Authors:  M Herten; S Stahlhoff; B Imm; E Schönefeld; A Schwindt; G B Torsello
Journal:  Radiologe       Date:  2016-03       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.